Skip to main content
. 2010 May;5(5):814–820. doi: 10.2215/CJN.07181009

Table 1.

Demographic and access data of the study population in December 2006 at time of randomization

AMP MPC P Value
Age 58.6 ± 11.5 57.4 ± 15.7 0.7
Race (black/white) 21/9 24/6 0.6
Gender (male/female) 19/11 16/14 0.6
Diabetes (yes/no) 9/21 17/13 0.07
Hb (g/dl) 11.9 ± 1.3 11.7 ± 1.4 0.8
EPO dose (1000 U/week) 12.8 ± 13.1 14.9 ± 17.9 0.6
Albumin 3.86 ± 0.40 3.91 ± 0.32 0.5
TSAT (%) 31.3 ± 10.6 29.4 ± 11.2 0.5
Ferritin (ng/ml) 791 ± 590 757 ± 412 0.8
Ferritin >800 ng/ml 11/29 14/30 0.6
Access (AV fistula/AV graft/CVC) 20/7/3 12/15/3 0.09

CVC, central venous catheter.